{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:05:10Z","timestamp":1709424310187},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.2169\/internalmedicine.2041-23","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T22:11:22Z","timestamp":1689718282000},"page":"677-680","source":"Crossref","is-referenced-by-count":0,"title":["Successful Management of Malignant Pericarditis Using Nivolumab for Metastatic Esophageal Squamous Cell Carcinoma"],"prefix":"10.2169","volume":"63","author":[{"given":"Yu","family":"Uneno","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Hosokai","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinosuke","family":"Kurakake","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Fuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Tamaoki","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikatoshi","family":"Katada","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Takayama T, Okura Y, Okada Y, et al. Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients. Int J Clin Oncol 20: 872-877, 2015.","DOI":"10.1007\/s10147-015-0794-7"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Thurber DL, Edwards JE, Achor RW. Secondary malignant tumors of the pericardium. Circulation 26: 228-241, 1962.","DOI":"10.1161\/01.CIR.26.2.228"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Klatt EC, Heitz DR. Cardiac metastases. Cancer 65: 1456-1459, 1990.","DOI":"10.1002\/1097-0142(19900315)65:6<1456::AID-CNCR2820650634>3.0.CO;2-5"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Mandard AM, Chasle J, Marnay J, et al. Autopsy findings in 111 cases of esophageal cancer. Cancer 48: 329-335, 1981.","DOI":"10.1002\/1097-0142(19810715)48:2<329::AID-CNCR2820480219>3.0.CO;2-V"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maher EA, Shepherd FA, Todd TJ. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 112: 637-643, 1996.","DOI":"10.1016\/S0022-5223(96)70046-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tsang TS, Seward JB, Barnes ME, et al. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Pro<i>c<\/i> 75: 248-253, 2000.","DOI":"10.4065\/75.3.248"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Oida T, Mimatsu K, Kano H, et al. Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J Gastroenterol 16: 740-744, 2010.","DOI":"10.3748\/wjg.v16.i6.740"},{"key":"8","unstructured":"8. Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36: 2921-2964, 2015."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kunitoh H, Tamura T, Shibata T, et al. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Brit J Cancer 100: 464-469, 2009.","DOI":"10.1038\/sj.bjc.6604866"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Okura Y, Kato K, Hanawa H, et al. Pericardial mesothelioma secreting thrombomodulin. Am Heart J 132: 1309-1311, 1996.","DOI":"10.1016\/S0002-8703(96)90490-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kato K, Cho BC, Takahashi M, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 20: 1506-1517, 2019.","DOI":"10.1016\/S1470-2045(19)30626-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hayashi K, Ando N, Watanabe H, et al. Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) trial (JCOG9407). Jpn J Clin Oncol 31: 419-423, 2001.","DOI":"10.1093\/jjco\/hye090"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sternbach G. Claude Beck: cardiac compression triads. J Emerg Med 6: 417-419, 1988.","DOI":"10.1016\/0736-4679(88)90017-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yu L, Guo QM, Wang Y, Xu Y, Liu L, Zhang XT. EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab. J Thorac Dis 13: 2404-2413, 2021.","DOI":"10.21037\/jtd-21-442"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Geddert H, Kiel S, Heep HJ, Gabbert HE, Sarbia M. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol 34: 850-856, 2003.","DOI":"10.1016\/S0046-8177(03)00342-3"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Burazor I, Imazio M, Markel G, Adler Y. Malignant pericardial effusion. Cardiology 124: 224-232, 2013.","DOI":"10.1159\/000348559"},{"key":"17","unstructured":"17. Mukai K, Shinkai T, Tominaga K, Shimosato Y. The incidence of secondary tumors of the heart and pericardium: a 10-year study. Jpn J Clin Oncol 18: 195-201, 1988."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Fraser RS, Viloria JB, Wang NS. Cardiac tamponade as a presentation of extracardiac malignancy. Cancer 45: 1697-1704, 1980.","DOI":"10.1002\/1097-0142(19800401)45:7<1697::AID-CNCR2820450730>3.0.CO;2-J"},{"key":"19","unstructured":"19. Attia S, Boussofara L, El Fekih L, et al. [Recurrent metastatic pericarditis treated by chemotherapy]. Tunis Med 86: 1027-1028, 2006 (in French)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yoshida K, Teramoto S. [A case of cardiac tamponade due to malignant pericarditis with lung adenocarcinoma, effectively treated with pericardial drainage and pemetrexed plus cisplatin chemotherapy]. Nihon Ronen Igakkai Zasshi 52: 421-424, 2015 (in Japanese, Abstract in English).","DOI":"10.3143\/geriatrics.52.421"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tomita Y, Sueta D, Kakiuchi Y, et al. Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody. Ann Oncol 28: 2893-2895, 2017.","DOI":"10.1093\/annonc\/mdx326"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_2041-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T03:38:14Z","timestamp":1709350694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_2041-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2041-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"article-number":"2041-23"}}